The interaction of hepatic lipid and glucose metabolism in liver diseases - PubMed (original) (raw)
Review
doi: 10.1016/j.jhep.2011.08.025. Epub 2011 Dec 13.
Affiliations
- PMID: 22173168
- DOI: 10.1016/j.jhep.2011.08.025
Free article
Review
The interaction of hepatic lipid and glucose metabolism in liver diseases
Lars P Bechmann et al. J Hepatol. 2012 Apr.
Free article
Abstract
It is widely known that the liver is a central organ in lipogenesis, gluconeogenesis and cholesterol metabolism. However, over the last decades, a variety of pathological conditions highlighted the importance of metabolic functions within the diseased liver. As observed in Western societies, an increase in the prevalence of obesity and the metabolic syndrome promotes pathophysiological changes that cause non-alcoholic fatty liver disease (NAFLD). NAFLD increases the susceptibility of the liver to acute liver injury and may lead to cirrhosis and hepatocellular cancer. Alterations in insulin response, β-oxidation, lipid storage and transport, autophagy and an imbalance in chemokines and nuclear receptor signaling are held accountable for these changes. Furthermore, recent studies revealed a role for lipid accumulation in inflammation and ER stress in the clinical context of liver regeneration and hepatic carcinogenesis. This review focuses on novel findings related to nuclear receptor signaling - including the vitamin D receptor and the liver receptor homolog 1 - in hepatic lipid and glucose uptake, storage and metabolism in the clinical context of NAFLD, liver regeneration, and cancer.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
- Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE, Renquist BJ. Geisler CE, et al. J Endocrinol. 2017 Jul;234(1):R1-R21. doi: 10.1530/JOE-16-0513. Epub 2017 Apr 20. J Endocrinol. 2017. PMID: 28428362 Review. - Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
Monteillet L, Gjorgjieva M, Silva M, Verzieux V, Imikirene L, Duchampt A, Guillou H, Mithieux G, Rajas F. Monteillet L, et al. Mol Metab. 2018 Oct;16:100-115. doi: 10.1016/j.molmet.2018.07.006. Epub 2018 Aug 1. Mol Metab. 2018. PMID: 30100243 Free PMC article. - Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.
Ma KL, Ruan XZ, Powis SH, Chen Y, Moorhead JF, Varghese Z. Ma KL, et al. Hepatology. 2008 Sep;48(3):770-81. doi: 10.1002/hep.22423. Hepatology. 2008. PMID: 18752326 - Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G, Gambino R, Cassader M. Musso G, et al. Prog Lipid Res. 2009 Jan;48(1):1-26. doi: 10.1016/j.plipres.2008.08.001. Epub 2008 Sep 9. Prog Lipid Res. 2009. PMID: 18824034 Review. - Nuclear receptors in liver disease.
Wagner M, Zollner G, Trauner M. Wagner M, et al. Hepatology. 2011 Mar;53(3):1023-34. doi: 10.1002/hep.24148. Epub 2011 Feb 11. Hepatology. 2011. PMID: 21319202 Review.
Cited by
- PANX1-mediated ATP release confers FAM3A's suppression effects on hepatic gluconeogenesis and lipogenesis.
Hu CQ, Hou T, Xiang R, Li X, Li J, Wang TT, Liu WJ, Hou S, Wang D, Zhao QH, Yu XX, Xu M, Liu XK, Chi YJ, Yang JC. Hu CQ, et al. Mil Med Res. 2024 Jun 27;11(1):41. doi: 10.1186/s40779-024-00543-6. Mil Med Res. 2024. PMID: 38937853 Free PMC article. - Evaluation of acute and sub-chronic toxicity of lithothamnion sp. in mice and rats.
Zhang Y, Tian R, Wu H, Li X, Li S, Bian L. Zhang Y, et al. Toxicol Rep. 2020 Jul 15;7:852-858. doi: 10.1016/j.toxrep.2020.07.005. eCollection 2020. Toxicol Rep. 2020. PMID: 32714840 Free PMC article. - Lipidomics for studying metabolism.
Han X. Han X. Nat Rev Endocrinol. 2016 Nov;12(11):668-679. doi: 10.1038/nrendo.2016.98. Epub 2016 Jul 29. Nat Rev Endocrinol. 2016. PMID: 27469345 Review. - Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study.
Knerr I, Coss KP, Kratzsch J, Crushell E, Clark A, Doran P, Shin Y, Stöckmann H, Rudd PM, Treacy E. Knerr I, et al. Pediatr Res. 2015 Sep;78(3):272-9. doi: 10.1038/pr.2015.107. Epub 2015 Jun 8. Pediatr Res. 2015. PMID: 26053138 - Anti-Obesity Effect of Combining White Kidney Bean Extract, Propolis Ethanolic Extract and CrPi3 on Sprague-Dawley Rats Fed a High-Fat Diet.
Abdelfattah DSE, Fouad MA, Elmeshad AN, El-Nabarawi MA, Elhabal SF. Abdelfattah DSE, et al. Nutrients. 2024 Jan 20;16(2):310. doi: 10.3390/nu16020310. Nutrients. 2024. PMID: 38276548 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials